Devil's claw

The plant trails along sandy ground, produces pink-purple tubular flowers and develops distinctive woody fruits with curved arms. A primary tuber supports the plant while secondary tubers are the traded material.

Southern African communities have used tuber preparations for pain, fever and digestive complaints. Commercial extracts are commonly standardised to iridoid glycosides such as harpagoside. Traditional use, herbal registration and clinical evidence are different evidence categories.

Poor harvesting can kill plants or remove too much regenerative tissue. A defensible lot records collector consent and terms, species verification, secondary-tuber harvest practice, drying loss and legal export documentation where applicable.

European herbal monographs recognise specified devil's-claw root preparations for traditional relief of minor joint pain and mild digestive complaints. Evidence is product- and preparation-specific; interactions, contraindications and delayed diagnosis remain relevant safety concerns.

Research has focused on iridoid glycosides and standardised extracts. Trade studies emphasise that ecological sustainability depends on harvest depth, retained primary tubers, recovery periods and transparent value distribution to harvesters.

A well-governed supply chain can generate dryland income with low land conversion. Key metrics include plant survival after harvest, harvest rotation, collector payment, rejected-material rates and reconciliation of fresh to dry mass.

Devil's claw is strongly associated with Indigenous and local knowledge in the Kalahari region. Access and benefit-sharing records should name the governing community or agreement only where publication consent exists.